Evidence map›Paper›PMID 41233972›Full record

ArticleIntestinal research2026

Ustekinumab-induced Henoch-Schönlein purpura in Crohn's disease: a case report and literature review.

Merih Deniz Toruner, Tugce Guvenir, Volkan Yilmaz, Ramazan Erdem Er, Murat Toruner

Abstract readCase Reports
In one paragraph

Article in Intestinal research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Merih Deniz TorunerDepartment of Gastroenterology, The Warren Alpert Medical School, Brown University, Providence, RI, USA.
Tugce GuvenirDepartment of Gastroenterology, Ankara University Faculty of Medicine, Ankara, Türkiye.
Volkan YilmazDepartment of Gastroenterology, Ankara University Faculty of Medicine, Ankara, Türkiye.
Ramazan Erdem ErDepartment of Gastroenterology, Ankara University Faculty of Medicine, Ankara, Türkiye.
Murat TorunerDepartment of Gastroenterology, Ankara University Faculty of Medicine, Ankara, Türkiye.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Crohn's disease is a chronic inflammatory disease of the digestive tract with extraintestinal manifestations, which include skin conditions, arthritis, ocular inflammation, and several autoimmune conditions. Dermatologic manifestations in Crohn's disease complicate the treatment course and prognosis and should be addressed promptly. Here, we report a 20-year-old male with a history of Crohn's disease, presenting with palpable purpura, consistent with Henoch-Schönlein purpura, upon administration of ustekinumab. The immunoglobulin A vasculitis was treated with prednisone and the discontinuation of ustekinumab. Due to the increased usage of biological agents in inflammatory bowel diseases, associations between biologics and vasculitides should be further studied in Crohn's disease patients for alternative treatment strategies and to understand potential adverse effects caused by biologics in Crohn's disease.

Indexed as

Case reportsCrohn diseaseIgA vasculitisInflammatory bowel diseasesUstekinumab

Identifiers

PMID41233972
PMCPMC12884125

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.